Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
Abstract Therapeutic efforts to engage the immune system against cancer have yielded exciting breakthroughs and a growing list of approved immune-based agents across a variety of disease states. Despite the early successes and durable responses associated with treatments such as immune checkpoint in...
Main Authors: | James L. Gulley, Elizabeth A. Repasky, Laura S. Wood, Lisa H. Butterfield |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2017-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-017-0262-1 |
Similar Items
-
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016
by: Prasad S. Adusumilli, et al.
Published: (2017-06-01) -
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
by: Christo Kole, et al.
Published: (2020-10-01) -
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
by: Paolo A. Ascierto, et al.
Published: (2018-07-01) -
The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting
by: Howard L. Kaufman, et al.
Published: (2017-04-01) -
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
by: Ariel E. Marciscano, et al.
Published: (2018-01-01)